Company Overview
| Stock Name | Hinsang Group |
|---|---|
| Stock Code | 06893 |
| Company Full Name | To be extracted |
| Industry | 消费零售 |
| Principal Activities | 主要從事以多個品牌開發、營銷、銷售及分銷個人護理產品(洗浴及沐浴露、洗髮露、護髮素及護膚產品)、保健產品(健康補充品、兒童專用開奶茶等)及家居產品(洗衣液及消毒殺菌劑)。 |
| Listing Date | 2014-10-16 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 香港九龍尖沙咀科學館道1號康宏廣場航天科技大廈12樓1213-1215室 |
| Business Address (Hong Kong) | 香港 新界 元朗 宏業西街11號 科技中心12樓B室 |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | www.hinsanggroup.com |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No |
Offering Information
| Offering Mechanism | Mechanism A |
|---|---|
| Offer Price | HK$ 1.18 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | 2014-10-08 to 2014-10-08 |
| Global Offering Shares | 200,000,000 shares |
| HK Public Offer Shares (Initial) | 20,000,000 shares (10.0%) |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | 180,000,000 shares (90.0%) |
| Offer Ratio | ~10.0% |
| Total Shares Post-IPO | 800,000,000 shares |
| Greenshoe (Over-allotment Option) | No |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | No cornerstone investors |
| Clawback Tiers | To be extracted |
| Reallocation Option | No |
| Total Global Offering Size | HK$ 236,000,000 |
Stock Connect Inclusion Analysis
| 26Q4 Regular Review | |
| Inclusion Pathway | Regular Path |
|---|---|
| HK Market Cap | HK$ 282.6M |
| Est. Threshold | HK$ 9.39B |
| Analysis Result | HK market cap below threshold, need +3223% |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | 純利約49.7百萬港元 |
| Period-End Cash Balance | 港元65.1百萬元 |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
Financial Data
Unit:
'000
HKD
Income Statement
| Item | 2012-03 | 2013-03 | 2014-03 |
|---|---|---|---|
| Revenue | 360,414 | 235,114 | 253,171 |
| Cost of sales | -258,945 | -136,704 | -110,830 |
| Gross profit | 101,469 | 98,410 | 142,341 |
| Other income and gains, net | 340 | 2,235 | 1,941 |
| Selling and distribution expenses | -29,079 | -31,515 | -34,529 |
| Administrative expenses | -44,219 | -43,892 | -47,923 |
| Net finance costs | -591 | -3,384 | -1,239 |
| Profit before tax | 27,097 | 19,781 | 61,175 |
| Income tax expense | -5,030 | -4,398 | -11,471 |
| Profit for the year | 22,067 | 15,383 | 49,704 |
| Profit attributable to owners | 22,067 | 15,383 | 49,704 |
Balance Sheet
| Item | 2012-03 | 2013-03 | 2014-03 |
|---|---|---|---|
| Cash and cash equivalents | 43,032 | 101,193 | 65,059 |
| Trade and bills receivables | 37,662 | 31,961 | 37,626 |
| Inventories | 29,518 | 17,226 | 12,999 |
| Total current assets | 117,645 | 179,336 | 115,684 |
| Total assets | 137,041 | 203,326 | 158,284 |
| Total current liabilities | 54,629 | 101,294 | 63,989 |
| Total liabilities | 56,815 | 107,574 | 63,989 |
| Total equity | 80,226 | 95,752 | 94,295 |
| Equity attributable to owners | 80,226 | 95,752 | 94,295 |
| Interest-bearing borrowings | 24,902 | 83,716 | 0 |
Cash Flow Statement
| Item | 2012-03 | 2013-03 | 2014-03 |
|---|---|---|---|
| Net cash from operating activities | 19,196 | 28,857 | 60,135 |
| Net cash from investing activities | -11,145 | -26,069 | -81,227 |
| Net cash from financing activities | 24,273 | 55,383 | -14,900 |
| Net increase in cash | 32,324 | 58,171 | -35,992 |
| Depreciation of PP&E | 1,943 | 2,023 | 1,771 |
| Purchase of PP&E | -4,063 | -7,069 | -13,408 |
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
| First Day Close | HK$ 1.37 |
|---|---|
| First Day Open | HK$ 1.61 |
| First Day Change | 16.10% |
| First Day Volume | 224482000.0 |
| First Day Turnover | 335865000.0 |
| Use of Proceeds | 1、最多48 %或約104.4百萬港元將用作發掘與新品牌擁有人的業務合作機會,其中包括:
1.1約10%的所得款項凈額用作進行可行性研究、盡職審查及研究以于中國挑選潛在品牌擁有人;
1.2約28%的所得款項凈額用作進行各種市場推廣活動以提高與該業務合作相關的品牌知名度;
1.3約10%的所得款項凈額用作加強整個集團的銷售支持及客戶服務以加強于目標市場的業務;
2、最多25%或約54.3百萬港元將用作擴充我們的銷售及分銷網絡,其中包括:
2.1約10%的所得款項凈額用作透過招聘更多推廣員,以于中國直接向客戶銷售我們的自家品牌產品,藉此擴充我們的銷售團隊;
2.2約10%的所得款項凈額用作將我們的分銷網絡擴充至中國的其他省份;
2.3約5 %的所得款項凈額用作加強我們的推廣員培訓活動,藉此支持及協助我們擴充我的銷售網絡覆蓋,其中包括中國、臺灣、澳門、新加坡及馬來西亞。
3、最多15%或約32.6百萬港元將用作加強我們于中國的營銷及宣傳活動,例如:
3.1以多方面的營銷策略提高我們的自家品牌知名度;
3.2透過不同的媒體及渠道加強我們的廣告活動,以于中國宣傳我們的自家品牌產品;
3.3繼續聘用品牌大使以宣傳我們的自家品牌產品;
4、最多6 %或約13百萬港元將用作擴充我們的產品組合,例如:
4.1委聘中國醫藥機構以對我們的產品進行實驗室測試及取得相關的許可證;
4.2以我們的自家品牌開發更多新中成藥及健康補充食品;
5、余下的6 %余額或約13百萬港元將用作本集團的一般營運資金。
|
Underwriting Syndicate
Sole Sponsor (1)
Ample Capital Limited CE AFZ323
Joint Bookrunners (2)
Joint Lead Managers (4)
Cornerstone Investors
This stock has no cornerstone investors.
Directors & Management
| Position | Chinese name | English Name |
|---|---|---|
| Chairman | 彭少衍 | — |
| Company Secretary | 蔡叔文 | — |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 彭少衍先生及關麗雯女士透過衍富持有緊隨資本化發行及股份發售完成後本公司全部已發行股本75%權益 |
|---|




